Need help understanding this study?
Leave your email and we’ll get in touch to discuss your questions and possible next steps.
Recruitment unclearEUCTR 2005-000223-42
Effects of ziprasidone vs. placebo during the first four weeks of eight weeks sertraline treatment in patients with PTSD (PTSD)
This historical record does not confirm current site availability.
Historical research recordGermany
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Who could participate?
This study is for people with PTSD. Other eligibility criteria apply.
- Listed locations
- Germany
- Compensation
- Payment and expense reimbursement have not been verified.
What to know before participating
A point to clarify
This is historical registry information. What is the current study status and protocol?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Recruitment unclear
- Enrollment listed in the registry
- 24
- Sponsor
- University Hospital Hamburg-Eppendorf, Psychiatry
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Germany
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2005-000223-42
- Official title
Show the full official title
Effects of ziprasidone vs. placebo during the first four weeks of eight weeks sertraline treatment in patients with posttraumatic stress disorder (PTSD)
Recruitment & locations
Status unknownGermany
Registry details
Historical country statuses
- Germany — Ongoing
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is University Hospital Hamburg-Eppendorf, Psychiatry, a hospital or academic medical center.
Who can participate?
This study is for people with PTSD. Other eligibility criteria apply.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
Recruitment unclearEUCTR 2018-001718-13
An Open- Label, Phase 2, Multicenter Feasibility Study if Manualized MDMA-Assisted Psychotherapy with an fMRI sub-study Assessing Changes in Brain Activity in Subjects with Posttraumatic Stress Dis...
United Kingdom, Czechia, Germany, + 3 others
Recruitment unclearEUCTR 2007-004286-18
Monocentric, Double-blind Placebo-Controlled, Randomized Cross-Sectional Clinical Trial of Hydrocortisone (10 and 30mg/d) in Outpatients with Posttraumatic-Stress- Disorder (PTSD) ...
Germany
RecruitingNCT07419594
Estradiol and Intrusive Memories
Germany